---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-21-010080"
form_type: "8-K"
ticker: "TENX"
cik: "0000034956"
company_name: "TENAX THERAPEUTICS, INC."
filed_at: "2021-09-14T23:59:59+00:00"
generated_at: "2026-06-29T03:57:27.596229+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Tenax Therapeutics loses audit committee independence after director resignation; Nasdaq grants cure period

## Summary
- Director James Mitchum resigned from the Board and its Audit and Compensation Committees effective Sept 8, 2021, for personal reasons.
- Resignation leaves the Audit Committee below the three independent members required by Nasdaq Listing Rule 5605(c)(2)(A).
- Nasdaq granted a cure period ending at the next annual meeting or March 7, 2022, whichever is earlier.
- Company has begun searching for a new independent director to serve on the Audit Committee.

## SEC filing metadata
- accession: 0001654954-21-010080
- form_type: 8-K
- ticker: TENX
- cik: 0000034956
- company_name: TENAX THERAPEUTICS, INC.
- filed_at: 2021-09-14T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01, 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/34956/000165495421010080/0001654954-21-010080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/34956/000165495421010080/tenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-21-010080
- JSON: https://secwatch.observer/filing/0001654954-21-010080.json
- Plain text: https://secwatch.observer/filing/0001654954-21-010080.txt

## Key facts
- Executive change
  James Mitchum resigned as Director at TENAX THERAPEUTICS, INC..
  - Action: resigned
  - Role: Director
  source text: On September 8, 2021, James Mitchum notified the Company that he is voluntarily resigning from the Board and its Audit and Compliance Committee and Compensation Committee, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/34956/000165495421010080/0001654954-21-010080-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.